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Abstract
The history of surgical treatment of Parkinson's disease (PD) covers more than 100 years.
It started from lesional approach and evolved to the final deep brain stimulation (DBS)
only in the 1990s. The aim of this treatment was to reduce clinical manifestation of PD and
drug intake by acting directly on the altered motor pathways. The typical targets are
represented by ventralis intermedius thalamic nucleus (VIM), internal globus pallidus
nucleus (GPi), and subthalamic nucleus (STN) with more recent extension on other
anatomical structures as pedunculopontine nucleus (PPN). Patients are selected according
to CAPSIT protocol and undergo DBS when medical treatment has failed to effectively
control the symptoms. Clinical benefits are represented by the reduction of “off” time and
“on” time with dyskinesia. However, even DBS treatment is characterized by complica‐
tions and side effects, as intracerebral hemorrhages, infections, ischemia, and seizures.
The recent introduction of neuronavigation systems and the amelioration in neuroradio‐
logical imaging quality simplified preoperative DBS planning and consequently reduced
surgical‐related problems
Keywords: Deep brain stimulation, Parkinson surgical treatment, DBS target, surgical
outcome, DBS complications
1. Introduction
The first experiences concerning surgical treatment of Parkinson's disease (PD) were made
between the end of the nineteenth century and the beginning of twentieth century by Sir V.
Horsely with surgery performed on cortical motor area. In the same period, Leriche et al. [1]
attempted to improve rigidity and tremor by focusing on pyramidal tracts, in particular trying
to interrupt abnormal motor signals by removing motor cortex, lesioning cervical spinal cord,
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or cerebral peduncle. Just before the World War II, the focus of surgical interest shifted to the
basal ganglia with the work of Meyers on pallidofugal fibers and Russell, which completed a
transventricular approach to remove the anterior two thirds of the caudate nucleus. Howev‐
er, the modern era can be traced by Spiegel [2] with the first stereotactic technique approach‐
ing globus pallidus (GPi). This author introduced the idea of a three‐dimensional spatial target
identification based on pneumoencephalography, ventriculography, and spatial relationship
of targets in relation to a reference line connecting the foramen of Monro to the posterior
commissure. In 1952, stereotactic thalamotomies were made in Freiburg, and between 1950 and
1960, surgical treatment of Parkinson was conducted in a quite homogeneous way by pallidot‐
omy and thalamotomy with remarkable improvement of both tremor and rigidity. During the
1960s, the discovery of levodopa effect on PD symptoms induced a loss of interest on surgical
treatment for almost three decades [3].
In the 1990s, the amelioration of diagnostic systems, with the introduction of computed
tomography (CT), and the awareness of the inevitability of levodopa side effects gave a
renewed strength to surgical approach to PD. However, Benabid and colleagues with chronic
deep brain stimulation (DBS) introduced the real change of PD surgical therapy [4]. The first
DBS target to be identified was ventral intermediate nucleus (Vim), followed later by subtha‐
lamic nucleus (STN) and internal segment of globus pallidus (GPi). In the following years,
after the approval of US FDA to STN and GPi DBS (2002), this technique rapidly obtained the
title of recognized therapy for advanced PD.
Recently, the introduction of magnetic resonance imaging (MRI)—Angio CT neuronaviga‐
tion, intraoperative neurophysiologic evaluation and frameless systems gave rise to further
improvements opening the doors to possible alternatives to the utilization of the classic
stereotactic frames.
2. Stereotactic systems
In almost all neurosurgical centers, stereotactic surgery is conducted by the utilization of classic
stereotactic frames in combination with either MRI or MRI and CT scan. This system is based
on the determination of spatial relationship between an identified target into the brain contest
and the frame rods visible on the MRI or CT images. Therefore, it is possible to determine the
exact location of the target in relation to the Cartesian axes as well as the trajectories angles
and the entry point. The computation of the coordinates and angles is performed by dedicat‐
ed computer systems and more frequently by the neuronavigation devices available on the
market. Finally, obtained coordinates and angle values are reported on specific millimetric
scales of the stereotactic frame in order to have a chosen position of the electrodes on the entry
point and along the planned trajectory to the target. During surgery, it is possible to perform
X‐ray control to confirm the exact position of the electrode in relation to the chosen target
(Figure 1).
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Figure 1. Stereotactic frame.
More recently, different companies have launched new frameless systems. This tools are based
on the utilization of external fiducials (usually 6) fixed to the skull and consequently record‐
ed on radiological studies (MRI and CT) acquired on the navigation system in order to
reconstruct the entire head volume and report chosen targets, entry points, and trajectories.
This new approach leaves the patient free from obliged and fixed position with less discom‐
fort and fatigue. Moreover, these new systems do not differ in accuracy from classic stereo‐
tactic frame (Figures 2 and 3).
Figure 2. Frameless system.
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Figure 3. Fiducials image on neuronavigation system.
3. Target identification
Although in recent years, we assisted to a progressive improvement of technology, there are
still strongholds that come from the past. In fact, neurosurgeons still consider the classical
Figure 4. Intercommissural line marked in blue on Gadolinium T1‐weighted sagittal MRI.
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Intercommissural Line (anterior commissure AC—posterior commissure PC line, AC‐PC line,
IC line) as a reference to determine stereotactic coordinates, which are consequently used as
starting points to find specific anatomical targets (indirect targeting methodology) (Figure 4).
However, recent amelioration of MRI quality allowed a direct visualization of most of
anatomical structures and a consequent easier direct surgical targeting (direct targeting
methodology). Although this technical progress, it is always recommended to use both
methods to adjust indirect final position to anatomical structures visible on MRI (Figure 5).
Figure 5. Trajectory planning on neuronavigation system.
The introduction of neuronavigation systems brought amelioration in pre‐surgical determi‐
nation of entry point and trajectory. Angio CT merged to Gadolinium T1‐weighted MRI can
better visualize vessels, bundles, and nuclei. Even if some authors do not consider strictly
necessary to have both T1‐weighted MRI and Angio CT for trajectories planning, sometimes
the resolution of a single exam could not allow a complete and satisfactory vision in particu‐
lar for small deep vessels (Figure 6).
Figure 6. Confrontation between Angio CT and Gadolinium T1‐weighted axial MRI; the arrow shows a vessel posteri‐
or to the trajectory only visible on Angio CT.
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Finally, it is important to remark the role of T2‐weighted or inversion recovery sequences for
the location of some anatomical structures, as STN or GPi, respectively, and proton density
studies for direct determination of PPN.
Generally, implantation procedure is made with an awoken patient because of the necessity
to stimulate the chosen target and avoid postoperative side effects. However, some authors
reported experience of DBS in Parkinson's patients under general anesthesia considering
secondary the neurophysiological aspect, and others just performed stimulation with macro
electrode.
Once the electrodes have been positioned in the proper targets, the stimulation device
(internal pulse generator, IPG) is hosted in a subclavicular subcutaneous pouch, and connec‐
tions among IPG, extension, and intracerebral electrodes are performed under general
anesthesia. An important consideration must be made about the number of electrode utiliz‐
ed during intraoperative recording that could vary from 1 to 5. An important concern, in
relation to this aspect, is in fact particularly linked to the necessity to find the best compro‐
mise between an efficient neurophysiologic test and the risk of hemorrhages.
Intraoperative electrical activity recording may give rise to a typical electrical pattern
depending on the anatomical structure found along the electrode trajectory. Stimulation could
also produce improvement of Parkinson's symptoms or induce different side effects giving
important information about the exact targeting and possible correction to be made in relation
to the obtained results.
4. Surgical aspects
In present times, deep brain stimulation (DBS) surgery can be performed with different
systems that share however two common starting points. These are represented by the
selection of PD patients and the choice of anatomical target.
4.1. Patient selection
The first attempt to standardize patient selection was developed in 1992 with the publication
of CAPIT (core assessment program for intracerebral transplantation) that had the purpose of
evaluate the outcome of patients selected for intracerebral transplantation of fetal dopamine
neurons [5]. The evolution of this protocol, which included also patients treated by ablative
and neurostimulation procedures, is represented by core assessment program for surgical
interventional therapies (CAPSIT), which have been published in 1999 [6]. This protocol gained
a growing importance during the last years and now represents the base for a correct selec‐
tion of PD patients. In fact, it is mandatory to choose patients in which the clinical benefits of
DBS overcome surgical risks connected to the procedure. Patients not only should be charac‐
terized by PD but also should be prepared in term of cognition, emotion, and social relations
to the DBS procedure in order to maximize the treatment effect.
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CAPSIT–PD inclusion criteria are as follows: idiopathic Parkinson's disease; duration of
illness >5 years; age between 35 and 70 years; improving UPDRS motor part of at least 40% at
the L‐Dopa test; persistence of severe disability at certain times of the day despite all the
adopted therapeutic strategies; antiparkinsonian therapy stabilized during the month before
the implant; absence of dementia (MMSE >24); absence of severe depression with suicidal
ideations; absence of psychosis; MRI within normal limits without evidence of marked
atrophy, or multiple abnormalities of vascular origin, or diseases interfering with the surgical
procedure (e.g., tumors); no history of drug addiction; absence of disease or medication
interfering with the coagulation.
These criteria describe three major groups of PD patients that could effectively benefit from
DBS surgery. The first group is represented by patients affected by idiopathic PD with normal
cognitive capacities that show motor fluctuations and dyskinesia despite optimal levodopa
therapy. Patients with controlled PD with persistent medication‐resistant tremor compose the
second group. Patients who do not tolerate medical treatment with consequently poor
symptoms control represent the third category of DBS candidates.
4.2. DBS target identification
Since Vim chronic stimulation has proven its efficacy only for tremor control, this nucleus is
not considered as a useful target for PD patient [7]. For this reason, possible stimulation sites
are chosen between internal globus pallidus (GPi) and subthalamic nucleus (STN) associat‐
ed in certain cases to pedunculopontine nucleus (PPN) [8]. The difference between STN and
GPi stimulation consists in a greater effect in controlling tremor by STN stimulation with a
consistent reduction of therapy intake and a consequent better control of psychiatric side
effects due to L‐Dopa. Conversely, targeting of GPi leads to a major anti‐dyskinetic effect but
leaves pharmacological dosage unchanged with all possible consequences on the psychiatric
condition. Nevertheless, even STN stimulation could produce psychiatric side effects con‐
cerning mood and behavioral troubles. Some authors consider the possibility to stimulate PPN
in order to obtain an improvement in axial manifestations such as postural instability or gait
dysfunction [9, 10].
4.2.1. Targeting of internal globus pallidus (GPi)
Internal globus pallidus nucleus could be identified using a direct or an indirect method.
According to the scheme reported by Laitinen, indirect targeting of the GPi is obtained, 2–3 
mm in front of the mid‐AC‐PC‐point, 3–6 mm caudal to intercommissural (IC) plane, and 20–
21 mm lateral to the AC‐PC line.
The planning requires the utilization of T2‐weighted or inversion recovery (IR) MRI to locate
the intercommissural line and draw the coordinate projection. T1‐contrast images are also used
to identify sulci gyri and vessels for the identification of safe trajectories avoiding vessels. GPi
can be found in the medial part of the globus pallidus, medial to the lamina medullaris interna
and lateral to the genu/posterior limb of internal capsule on the axial plane. Coronal plane can
be used to obtain a better definition of GPi's relationship with optic radiations. Once the target
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is reached, intraoperative recording shows a specific electrical pattern consisting in a high
frequency activity with 40 spikes/s of tonic firing [11]. Visual spots are conversely evocated
when the electrode trespasses on the optic radiations. This sign is important to determine the
lower boundary of the GPI and to avoid visual impairments once the device is completely
implanted and programmed (Figures 7 and 8).
Figure 7. Electrode final position in GPI.
Figure 8. Intraoperative GPI recording.
4.2.2. Targeting of subthalamic nucleus (STN)
Indirect coordinates of the STN are reported as 3–4 mm posterior to mid‐AC‐PC‐point, 3–5 
mm below the AC‐PC line, 11–12 mm lateral to AC‐PC line. MRI images and in particular T2‐
weighted acquisitions may give a clear vision of the subthalamic nucleus as well as its
anatomical relationship with other structures such as red nucleus, Forel's fields, and zona
incerta (Figure 9).
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Figure 9. Final electrode position showed on CT merged to T2‐axial MRI.
Neurophysiological intraoperative monitoring could give important information not only
evidencing the typical electrical pattern of STN (STN neurons are characterized by a mean
firing rate of 42.30 ± 22.00 spikes/sec (mean ± SD); the STN cells exhibited irregular or bursty
discharge pattern) but also inducing improvement of Parkinson's symptoms or even side
effects as paresthesias, muscular spasticity, diplopia, speech difficulties, and neurovegeta‐
tive alterations [11, 12]. Therefore, neurophysiological intraoperative tests play an important
role for the determination of the final electrode position, in order to maximize the benefit and
avoid side effects lied to a possible brain shift secondary to CSF leakage and air penetration.
During target planning, an important step is to avoid the anterior part of the STN, which is
involved not only in extrapyramidal pathways but also in limbic circuits. Effectively, a
stimulus that involves the anterior part of STN may cause behavioral changes, depression,
Figure 10. Intraoperative recording of STN electrical activity.
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maniac episodes, and other psychiatric complications. The diffusion of the stimulus to the
substantia nigra may also give rise to psychiatric problems such as major depression and
hypomania [13] (Figure 10).
4.2.3. Targeting ventralis intermedius thalamic nucleus (VIM)
VIM stimulation is used in patients affected by tremor (parkinsonian or essential), and its
indirect target is 25–50% of AC‐PC length from PC at IC plane, ½ (third ventricular width)
+11.5 mm. These coordinates are actually reported on MRI images, where the nucleus is not
normally visible on 3 Tesla MRI. Recorded electrical pattern has no specific features and does
not differ from other sites within the thalamus. Conversely, the stimulation test can be very
useful not only in reducing or abolishing tremor immediately but also in defining the
boundaries of the VIM by evocating paresthesia or other sensitive symptoms secondary to the
stimulation of the VPL nucleus [14] (Figures 11 and 12).
Figure 11. Final electrodes position in VIM showed on neuronavigation system.
Figure 12. Intraoperative VIM recording showing typical low‐frequency spikes synchronized with tremor.
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4.2.4. Targeting of pedunculopontine nucleus (PPN)
The stimulation of this nucleus is utilized to reduce or abolish gait disturbances and freezing.
The indirect localization may be obtained considering a line passing anterior to the floor of the
fourth ventricle on a line running along the pontomesencephalic longitudinal axis
(Figure 13).
Figure 13. Gadolinium T1‐sagittal MRI showing indirect localization of PPN; the red tract above the fastigial line indi‐
cates the location of PPN.
Figure 14. Proton density axial MRI; the arrow shows the PPN location; the blue area indicates the periaqueductal grey
matter, the violet circle indicates the red nucleus/decussation of anterior cerebellar peduncle, the green oval indicates
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lateral lemniscus and the red area indicates the medial lemniscus/spinothalamic tract; on the left side of the image, the
anatomical structures are visible in the real grey scale.
This line is crossed by an orthogonal line traced through the fastigium in order to identify a
superior and inferior component of the previous identified line. Using this reference system,
the PPN is identified 6 mm lateral and 4 mm anterior to the pontomesencephalic/fastigial
lines, 16 mm above the crossing point between the base point fastigial line. The direct
localization may be obtained by MRI identification using proton density images. The target is
identified on an axial slice passing through the inferior colliculus in an area localized among
the decussation of anterior cerebellar peduncle anteriorly, medial lemniscus anterolaterally,
lateral lemniscus and spinothalamic tracts posterolaterally, periaqueductal gray matter and
middle longitudinal fasciculus medially (Figure 14).
Recording of this area does not give specific information, while stimulation may be helpful in
determining the exact position of the electrode contacts in relation to the absence of evoked
side effects. The diffusion of the stimulus to the close structures could cause sensitive
disturbances in case of stimulation of the lemniscal/spinothalamic bundles, hearing and
vertigo stimulating medial lemniscus, diplopia secondary to the activation of third cranial
nerve sub‐nuclei, neurovegetative imbalance for the stimulation of central tegmental neu‐
rons [15].
5. IPG programming
IPG programming takes place after a first period of postoperative rest in order to focalize better
the real effect of DBS without the bias related to the surgical damage secondary to leads
introduction. The optimization of IPG stimulation pattern could necessitate several months,
usually from 4 to 6. Each electrode can range from four to eight contacts that could be spaced 0.5
or 1.5 mm, and the stimulation could be made in a monopolar or bipolar way. The chosen
configuration should be characterized by the best clinical effect with the smallest amount of
side effects, which could derive from the extension of electrical stimulation to neighboring
anatomical structures.
Once IPG setting is completed, the attention is focalized on stimulation amplitude, which is
usually increased gradually in order to obtain a reduction in antiparkinsonian drug intake
while preserving clinical wellness [16].
Finally, it is important to pay attention to frequency stimulation. Since the beginning of DBS
treatment, high‐frequency stimulation (above 130 Hz) has been considered the base of clinical
improvement. However, more recently several authors showed the great potential of inter‐
mediate frequencies (60–80 Hz) in particular on freezing and gait even if the clinical benefit
could be only temporary [17, 18].
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6. Outcomes
Recent randomized controlled clinical trials on GPi and STN DBS showed that these treat‐
ments are superior to PD medical management alone [19].
As reported in a review by Duker et al. [16] PD DBS patients could obtain almost 4.4–4.6 h per
day of “on” time without dyskinesia and a reduction of 1–2.6 h per day of “on” time with
dyskinesia and 2.4–4.2 h per day of “off” time.
Since it has been proved that STN and GPi DBS are characterized by the absence of differ‐
ence in motor function, the selection of the anatomical target should rely on patient peculiar‐
ities and surgeon preference [10].
7. Timing of DBS in Parkinson patients
In the last years, several authors focused their attention on DBS timing, reporting the hypoth‐
esis of a larger and more lasting amelioration of PD symptoms with early surgical treatment.
As reported by Schuepbach et al. [20] in 2013, an earlier DBS could in fact improve patient
quality of life better than medication alone even only after 2 years of PD. Conversely till
nowadays, DBS solution was reserved usually for patients that had a minimum history of 5 
years of disease and motor symptoms that did not improved with optimized medical
therapy [6]. More studies are, however, necessary in order to further verify this hypothesis
and to clarify long‐term efficacy of this early surgical approach [16].
8. Complications and side effects
Although DBS is a relatively safe and effective procedure, complications and side effects
represent a rare but unavoidable constant in this surgical treatment. As reported by recent
literature reviews, adverse effects can be divided into 3 time‐related categories: intraopera‐
tive, perioperative (<2 weeks), and long‐term postoperative complications (>2 weeks).
Intraoperative adverse events are represented by intracerebral (ICH) and intraventricular
(IVH) hemorrhage, acute perilesional edema, cortical/subcortical ischemic infarction, vasova‐
gal response and hypotension, confusion, anxiety, seizure, arrhythmia, and aborted proce‐
dure. Perioperative complications, which arise during the first 2‐week postop, are headache,
hemiparesis, confusion, agitation, respiratory distress, seizure, hallucinations, somnolence,
and falls. Conversely, long‐term postoperative complications are represented by wound
complications (infection, skin erosion, wound dehiscence), hardware complications (lead
fracture/malposition/migration/malfunction, flipped IPG, malpositioned/uncomfortable/
malfunctioning internal pulse generator (IPG), lead extension malfunction/fracture), and
satisfaction‐related complications (loss of system efficacy over time, decreased efficacy over
time) [21].
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The recent improvement in pre‐surgical target planning, with the introduction of neuronavi‐
gation systems, and the quality improvement of neuroradiological imaging are decreasing the
rate of intracranial hematomas connected to electrodes placement. However, this complica‐
tion remains possible with all consequent damages ranging from minor asymptomatic
bleedings to huge hemorrhages with fatal consequences. Medical treatment is based on
administration of mannitol or steroids, depending on the clinical and radiological character‐
istics of the hematoma, and could be associated to surgical cloth evacuation.
Infections represent another important DBS complication. Infection sites are frequently located
at the level of the pouch created for the device, more rarely along the extension cables
(usually due to a propagation from the infected device pouch) or on the intracranial exten‐
sion of the electrodes, with consequent meningitis, subdural empyema, or intracerebral
abscess. Antibiogram, specific antibiotic treatment, and removal of the infected components
are mandatory except in case of superficial skin infection with no propagation of the compo‐
nents of the implanted system.
Wound dehiscence is usually caused by cutaneous decubitus of stimulation device. This
complication is often related to a subsequent infection frequently caused by saprophytes
cutaneous germs. It requires wound reopening, tissue debridement, and change or increase of
the pouch volume.
Dislocation may be possible due to the relative tenderness of the electrode tip that could deviate
from the chosen target. In order to reduce this possibility, it is advisable to use long cannu‐
las to guide the electrode to the target.
Sometimes the electrode may move upward or downward from the target. This problem is
often related to a blockage failure and requires the removal of the electrode and a new surgical
positioning.
The brain is normally contained in a liquid environment formed by cerebrospinal fluid (CSF).
During surgery, a certain volume of CSF leaks trough the surgical opening giving rise to a
change in spatial relationship between the brain and the skull. In order to minimize, this
problem many authors planned different solutions but a minimal amount of brain shift is still
unavoidable. Obviously, a careful and minimal opening of the skull and meninges and the
neurophysiological intraoperative recording may minimize this effect without affecting the
surgical outcome (Figure 15).
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Figure 15. Fibrin glue and hemostatic sponge used as a plug to minimize CSF leakage.
A careful planning and intraoperative neurophysiological evaluation is usually sufficient to
avoid side effects. However, complications as brain shift, electrode dislocation, or difficulty to
evidence the evoked symptoms due to poor cooperation and reliability of the patient could
cause postoperative problems. Propagation of the stimulus outside the planned target could
induce pyramidal symptoms occurring by to the internal capsule, eye movement imbalance,
appraisal, or worsening of dysarthria, psychiatric alteration, paresthesia, or skin numbness
(this last complication normally disappears rapidly thanks to neuronal adaptation). Moreover,
attention must be paid during trajectory planning to avoid caudate nucleus, in order to prevent
cognitive deterioration.
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